Cough syrup row: Reports of contaminated medicines came out in 2022 in The Gambia, with subsequent reports in Indonesia, Uzbekistan, and Micronesia; all the products under the scanner are syrup-based
Gambia has announced that all pharmaceutical products from India must be inspected and tested before shipment from 1 July, following the deaths of dozens of children linked to Indian-made cough syrups.
Gambia's latest move is to "address issues related to substandard and falsified (counterfeit) medicines entering the country", the executive director of its Medicines Control Agency (MCA), Markieu Janneh Kaira, wrote in a letter to India's drug controller general, Rajeev Singh Raghuvanshi, dated June 15.
Gambia cough syrup deaths: A report by a team of international experts blamed tainted medicine from India for an outbreak of kidney failure that killed more than 60 Gambian children last year
Health Minister Mansukh Mandaviya said that an extensive risk-based analysis is done continuously to ensure the production of quality medicines in the country, and the government and regulators are always alert to ensure that no one dies due to spurious medicines. Get more India News and Business News on Zee Business.